Beverly Alston

2.2k citations

19 papers · 1.7k indexed · 1 hit paper · h-index 13

Co-authors: Judith A. Aberg Carl J. Fichtenbaum Kenneth E. Sherman Marion G. Peters Margaret James Koziel Raymond T. Chung Charles van der Horst Janet Andersen
Topics: HIV/AIDS drug development and treatment (10 papers)HIV Research and Treatment (8 papers)HIV-related health complications and treatments (7 papers)
Cited by: Hepatology Virology Emergency Medicine
Journals: New England Journal of Medicine Annals of Internal Medicine The Journal of Clinical Endocrinology & Metabolism
Partner nations: United States Israel

In The Last Decade

Beverly Alston

19 papers receiving 1.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Peginterferon Alfa-2a plus Ribavirin versus Interferon Alfa-2a plus Ribavirin for Chronic Hepatitis C in HIV-Coinfected Persons

2004 674 citations Raymond T. Chung, Janet Andersen et al. New England Journal of Medicine profile →

Peers

Countries citing papers authored by Beverly Alston

Since Specialization

Citations

This map shows the geographic impact of Beverly Alston's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Beverly Alston with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Beverly Alston more than expected).

Fields of papers citing papers by Beverly Alston

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Beverly Alston. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Beverly Alston. The network helps show where Beverly Alston may publish in the future.

Co-authorship network of co-authors of Beverly Alston

This figure shows the co-authorship network connecting the top 25 collaborators of Beverly Alston. A scholar is included among the top collaborators of Beverly Alston based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Beverly Alston. Beverly Alston is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

#	Work	Indexed citations
1	Sustained Long-Term Antiviral Maintenance Therapy in HCV/HIV-Coinfected Patients (SLAM-C) 2010 ·JAIDS Journal of Acquired Immune Deficiency Syndromes ·Kenneth E. Sherman,Janet W. Andersen,Adeel A. Butt,Triin Umbleja,Beverly Alston,Margaret James Koziel,Marion G. Peters,Mark Sulkowski,Zachary Goodman,Raymond T. Chung	20
2	Pharmacokinetic evaluation of the effects of ribavirin on zidovudine triphosphate formation: ACTG 5092s Study Team 2007 ·HIV Medicine ·(unknown),Min‐Hee Kang,(unknown),Patricia Lizak,Beverly Alston,(unknown)	11
3	Effects of Testosterone Supplementation on Whole Body and Regional Fat Mass and Distribution in Human Immunodeficiency Virus-Infected Men with Abdominal Obesity 2006 ·The Journal of Clinical Endocrinology & Metabolism ·Shalender Bhasin,Robert A. Parker,Fred R. Sattler,Richard Haubrich,Beverly Alston,Triin Umbleja,Cecilia M. Shikuma	86
4	Pharmacokinetic interaction between nelfinavir and pravastatin in HIV-seronegative volunteers: ACTG Study A5108 2006 ·AIDS ·Judith A. Aberg,Susan L. Rosenkranz,Carl J. Fichtenbaum,Beverly Alston,Susan W. Brobst,Yoninah Segal,John G. Gerber	32
5	A Randomized Trial of the Efficacy and Safety of Fenofibrate versus Pravastatin in HIV-Infected Subjects with Lipid Abnormalities: AIDS Clinical Trials Group Study 5087 2005 ·AIDS Research and Human Retroviruses ·Judith A. Aberg,Robert Zackin,Susan W. Brobst,Scott Evans,Beverly Alston,W. Keith Henry,Marshall J. Glesby,Francesca J. Torriani,Yijun Yang,Susan Owens,Carl J. Fichtenbaum	97
6	Effect of Efavirenz on the Pharmacokinetics of Simvastatin, Atorvastatin, and Pravastatin 2005 ·JAIDS Journal of Acquired Immune Deficiency Syndromes ·John G. Gerber,Susan L. Rosenkranz,Carl J. Fichtenbaum,José M. Vega,Amy Y. Yang,Beverly Alston,Susan W. Brobst,Yoninah Segal,Judith A. Aberg	136
7	Absence of Sustained Hyperlactatemia in HIV-Infected Patients With Risk Factors for Mitochondrial Toxicity 2004 ·JAIDS Journal of Acquired Immune Deficiency Syndromes ·David A. Wohl,Christopher D. Pilcher,Scott B. Evans,(unknown),Grace A. McComsey,Yijun Yang,Robert Zackin,Beverly Alston,(unknown),Michael Basar,Angela D. M. Kashuba,(unknown),Ana Martı́nez,(unknown),Joseph Quinn,(unknown),(unknown),Susan L. Koletar	14
8	A phase II, double-masked, randomized, placebo-controlled evaluation of a human monoclonal anti-Cytomegalovirus antibody (MSL-109) in combination with standard therapy versus standard therapy alone in the treatment of AIDS patients with Cytomegalovirus retinitis 2004 ·Antiviral Research ·Michael J. Borucki,John Spritzler,David M. Asmuth,J. W. Gnann,(unknown),Mostafa Nokta,Francesca Aweeka,(unknown),(unknown),Beverly Alston	27
9	Peginterferon Alfa-2a plus Ribavirin versus Interferon Alfa-2a plus Ribavirin for Chronic Hepatitis C in HIV-Coinfected Personsbreakdown → 2004 ·New England Journal of Medicine ·Raymond T. Chung,Janet Andersen,Paul A. Volberding,Gregory K. Robbins,Tun Liu,Kenneth E. Sherman,Marion G. Peters,Margaret James Koziel,Atul K. Bhan,Beverly Alston,(unknown),(unknown),George Harb,Charles van der Horst	674
10	Changes in Weight and Lean Body Mass during Highly Active Antiretroviral Therapy 2004 ·Clinical Infectious Diseases ·Cecilia M. Shikuma,Robert Zackin,Fred R. Sattler,Donna Mildvan,(unknown),Beverly Alston,Scott Evans,Kathleen Mulligan	49
11	A phase II, double-masked, randomized, placebo-controlled evaluation of a human monoclonal anti-Cytomegalovirus antibody (MSL-109) in combination with standard therapy versus standard therapy alone in the treatment of AIDS patients with Cytomegalovirus retinitis 2004 ·Antiviral Research ·Michael J. Borucki,John Spritzler,David M. Asmuth,J. W. Gnann,(unknown),Mostafa Nokta,Francesca Aweeka,(unknown),(unknown),Beverly Alston	9
12	Correlation of Single Photon Emission Computed Tomography Parameters as a Noninvasive Alternative to Liver Biopsies in Assessing Liver Involvement in the Setting of HIV and Hepatitis C Virus Coinfection: A Multicenter Trial of the Adult AIDS Clinical Trials Group 2003 ·JAIDS Journal of Acquired Immune Deficiency Syndromes ·Bruce Shiramizu,Dickens Theodore,Roland L. Bassett,Marc N. Coel,Kenneth E. Sherman,Marshall J. Glesby,Dominic C. Chow,Beverly Alston,(unknown),(unknown),Richard C. Reichman,Ruth Berggren,(unknown),Susan W. Brobst	5
13	Pharmacokinetic interactions between protease inhibitors and statins in HIV seronegative volunteers: ACTG Study A5047 2002 ·AIDS ·Carl J. Fichtenbaum,John G. Gerber,Susan L. Rosenkranz,Yoninah Segal,Judith A. Aberg,Terrence F. Blaschke,Beverly Alston,Fang Fang,Bradley W. Kosel,Francesca Aweeka	272
14	The Closeout Process for a Clinical Trial Terminated Early for Lagging Enrollment and Inadequate Follow-up 2001 ·Controlled Clinical Trials ·K Muth,Eunice Yu,Beverly Alston,Jonas H. Ellenberg	10
15	The safety and efficacy of adefovir dipivoxil in patients with advanced HIV disease: a randomized, placebo-controlled trial 2001 ·AIDS ·Evelyn J. Fisher,Kathryn Chaloner,David L. Cohn,(unknown),Beverly Alston,Carol Brosgart,Barry Schmetter,Wafaa El‐Sadr,James Sampson	76
16	A Multicenter, Randomized, Controlled Trial of Three Preparations of Low-Dose Oral α-Interferon in HIV-Infected Patients With CD4+ Counts Between 50 and 350 cells/mm3 1999 ·JAIDS Journal of Acquired Immune Deficiency Syndromes ·Beverly Alston,Jonas H. Ellenberg,Harold C. Standiford,K Muth,Ana Martı́nez,Wayne Greaves,(unknown)	12
17	A Multicenter, Randomized, Controlled Trial of Three Preparations of Low-Dose Oral α-Interferon in HIV-Infected Patients With CD4+ Counts Between 50 and 350 cells/mm3 1999 ·JAIDS Journal of Acquired Immune Deficiency Syndromes ·Beverly Alston,Jonas H. Ellenberg,Harold C. Standiford,K Muth,Ana Martı́nez,Wayne Greaves,(unknown)	11
18	A randomized, placebo-controlled trial of the safety and efficacy of oral ganciclovir for prophylaxis of cytomegalovirus disease in HIV-infected individuals 1998 ·AIDS ·Carol Brosgart,Thomas A. Louis,David W. Hillman,Charles P. Craig,Beverly Alston,Evelyn J. Fisher,Donald I. Abrams,Roberta Luskin‐Hawk,James Sampson,(unknown),Melanie Thompson,Ramón A. Torres	44
19	Weekly Fluconazole for the Prevention of Mucosal Candidiasis in Women with HIV Infection 1997 ·Annals of Internal Medicine ·Paula Schuman,Linnea Capps,Grace Peng,Federico Vázquez,Wafaa El-Sadr,Anne I. Goldman,Beverly Alston,C. Lynn Besch,Anita Vaughn,Melanie Thompson,(unknown),Thomas M. Kerkering,Jack D. Sobel	88

About Beverly Alston

Beverly Alston is a scholar working on Virology, Emergency Medicine and Infectious Diseases, having authored 19 papers that have together received 1.7k indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (10 papers), HIV Research and Treatment (8 papers) and HIV-related health complications and treatments (7 papers). The work is most often cited by research in Hepatology (722 citations), Virology (349 citations) and Emergency Medicine (527 citations). Beverly Alston has collaborated with scholars based in United States and Israel. Frequent co-authors include Judith A. Aberg, Carl J. Fichtenbaum, Kenneth E. Sherman, Marion G. Peters, Margaret James Koziel, Raymond T. Chung, Charles van der Horst, Janet Andersen, Tun Liu and Atul K. Bhan. Their work appears in journals such as New England Journal of Medicine, Annals of Internal Medicine and The Journal of Clinical Endocrinology & Metabolism.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact